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Abstract
Peptidoglycan is the major structural component of the Staphylococcus aureus cell wall, in
which it maintains cellular integrity, is the interface with the host, and its synthesis is targeted
by some of the most crucial antibiotics developed. Despite this importance, and the wealth
of data from in vitro studies, we do not understand the structure and dynamics of peptidogly-
can during infection. In this study we have developed methods to harvest bacteria from an
active infection in order to purify cell walls for biochemical analysis ex vivo. Isolated ex vivo
bacterial cells are smaller than those actively growing in vitro, with thickened cell walls and
reduced peptidoglycan crosslinking, similar to that of stationary phase cells. These features
suggested a role for specific peptidoglycan homeostatic mechanisms in disease. As S.
aureusmissing penicillin binding protein 4 (PBP4) has reduced peptidoglycan crosslinking
in vitro its role during infection was established. Loss of PBP4 resulted in an increased
recovery of S. aureus from the livers of infected mice, which coincided with enhanced fitness
within murine and human macrophages. Thicker cell walls correlate with reduced activity of
peptidoglycan hydrolases. S. aureus has a family of 4 putative glucosaminidases, that are
collectively crucial for growth. Loss of the major enzyme SagB, led to attenuation during
murine infection and reduced survival in human macrophages. However, loss of the other
three enzymes Atl, SagA and ScaH resulted in clustering dependent attenuation, in a zebra-
fish embryo, but not a murine, model of infection. A combination of pbp4 and sagB deficien-
cies resulted in a restoration of parental virulence. Our results, demonstrate the importance
of appropriate cell wall structure and dynamics during pathogenesis, providing new insight
to the mechanisms of disease.
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Author summary
The prevalence of methicillin resistant Staphylococcus aureus (MRSA) in both hospitals
and the wider community places a huge weight on healthcare providers. To discover new
control regimes, it is therefore important to understand how the pathogen behaves within
the relevant environment of the host. This is often hampered by the ability to obtain suffi-
cient ex vivo pathogen samples for study. We have developed a method to isolate S. aureus
from the infected host to be able to analyse cellular morphology and structure. S. aureus,
isolated from an infected kidney abscess are smaller in size, with thicker cell walls than
exponentially growing cells in vitro. Their cell wall peptidoglycan also is less crosslinked.
These features suggested the role of components controlling cell wall homeostasis as being
important for infections. We tested the role of PBP4, known to increase cell wall crosslink-
ing and found a pbp4 mutant to have increased survival in macrophages and fitness within
the murine host. Conversely the peptidoglycan hydrolase SagB, whose loss results in thin-
ner cell walls was attenuated in the murine systemic model of infection, with concomitant
loss of fitness within macrophages. Our study reveals an important adaptation to the host
environment and the role of those components involved in cell wall homeostasis in vivo.
Introduction
Staphylococcus aureus is adaptable, it exists as a commensal, colonising the nares and skin of
around 30% humans [1], but also has the capacity to be a serious opportunist pathogen, often
through injury or medical intervention [2]. Upon entering a host, S. aureus can infect a wide
repertoire of sites around the body, causing skin and soft tissue infection (SSTIs), sepsis, osteo-
myelitis, peritonitis, pneumonia and endocarditis [3]. Also, infections are inherently dynamic
as they progress from establishment, to resolution or potentially host mortality [4]. Such versa-
tility is manifested by physiological adaptation to a changing environment. The cell wall forms
the interface between S. aureus and the human host, where it not only is essential for viability
of the bacterium but remains dynamic during growth and interacts with the host immune sys-
tem. Despite this importance, the structure and dynamics of the cell wall during infection are
poorly understood.
Peptidoglycan (PG) is the major component of the cell wall and surrounds the cytoplasmic
membrane as a single macromolecule, forming the sacculus [5]. PG consists of glycan chains
made of alternating N-Acetylmuramic acid (MurNAc) and N-Acetylglucosamine (GlcNAc)
residues which are connected by short peptides that are peptides bound to the MurNAc
residues [6]. The nascent stem peptides in S. aureus PG consists of L-alanine, D-isoglutamine,
L-lysine with a penta-glycine attached to the epsilon amino group, and a terminal D-alanine-D-
alanine [7,8].
Crosslinks in PG produce a three-dimensional mesh with strength and rigidity [9]. In S.
aureus, up to 80–90% of the stem peptides are linked by a 3–4 crosslink via the pentaglycine
bridge [10]. S. aureus PG has a reduced crosslinking in stationary phase compared to exponen-
tial phase when grown in vitro in synthetic medium, which could be due to glycine depletion
[11]. PG can also be modified after its synthesis by O-acetylation of MurNAc residues [12],
which in S. aureus contributes to lysozyme resistance and pathogenicity [13,14].
PG plays an important role in host-pathogen interactions, with host receptors including
nucleotide-binding oligomerisation domain protein (NOD) 1 and NOD2 recognising specific
PG motifs. Detection of muropeptides by NOD1 or 2 results in the secretion of cytokines such
as interleukin (IL) 6 and tumour necrosis factor alpha (TNF-α) [15], and the activation of the
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NF-κB pro-inflammatory cascade [16] causing the transcription of pro-inflammatory cyto-
kines and leukocyte recruitment to help to clear bacterial infection [17]. PG can also augment
S. aureus infection when co-administered in a murine sepsis model of infection [18].
Growth and cell division require both PG synthases and hydrolases [5]. Penicillin binding
proteins (PBPs) complete the final stages of PG synthesis, performing the glycosyltransferase
and/or the transpeptidase reactions required to synthesize nascent PG and incorporate it into
the sacculus [19]. S. aureus possesses 4 native PBPs. The transpeptidase PBP1 is essential for
growth [20] and division septa formation [21,22]. PBP2 is essential and has glycosyltransferase
and transpeptidation activities [23]. The non-essential PBP3 is a monofunctional transpepti-
dase [24] interacting with RodA for the correct localisation at mid-cell and the insertion of PG
at sites other than the septum [25]. PBP4 is responsible for the high cross-linkage in the PG of
S. aureus [26] consistent with its high activity in vitro [27]. PBP4 is required for β-lactam resis-
tance in community-acquired MRSA strains [28]. A pbp4 mutant caused larger skin lesions,
without increased bacterial load, compared to a wildtype S. aureus in a murine skin abscess
model of infection [29], suggesting an increased virulence from exacerbated disease presenta-
tion. This was hypothesised to be caused by an increased production of host IL-1β [29]. MRSA
strains also encode the non-native mecA gene, encoding PBP2A, responsible for low level β-
lactam antibiotic resistance, or high level when present with specific rpoB and rpoC mutations
[30]. S. aureus making PBP2A produces PG with a low level of crosslinking, similar to that of
pbp4 mutants, when all native PBPs are inactivated by the presence of β-lactam antibiotic. This
indicates that PBP2A can produce a basal level of PG cross-links to facilitate cell survival in the
presence of β-lactams, but it cannot complement for the loss of PBP4 function, resulting in
low PG cross-linkage [29]. Mice infected with MRSA and then treated with β-lactam antibiot-
ics (therefore producing bacteria with poorly crosslinked PG) developed significantly larger
lesions in comparison to mice treated with PBS [29]. The MRSA strain S. aureus COL is viable
with only PBP1 and PBP2 with no impact on cell growth or morphology, but is attenuated in a
Drosophila model of infection compared to a wildtype COL strain [31].
S. aureus has multiple PG hydrolases allowing the cleavage of the glycan backbone and side-
chains. N-acetyl-β-D-muramidases (muramidases, including the subset of lytic transglycosy-
lases) cleave after the N-acetylmuramic acid residue in the glycan backbone, whereas N-acetyl-
β-D-acetylglucosaminidases (glucosaminidases) cleave after the N-acetylglucosamine moiety
[32]. The genome of S. aureus encodes for two putative lytic transglycosylases (IsaA and SceD)
[33], as well as four putative glucosaminidases (Atl, SagB, SagA and ScaH) [34,35]. S. aureus
Atl is bifunctional, containing both a cell wall amidase and a glucosaminidase domain [36,37].
Atl is the major autolysin of S. aureus and is involved in the separation of daughter cells, dem-
onstrated by the formation of clusters in atl deletion mutants [37], but this does not impact
upon virulence [38]. A more recent study has shown that the loss of glucosaminidase results in
clustering and attenuation in a murine model of osteomyelitis [39]. The glucosaminidase SagB
is responsible for cleaving glycans to their mature length [34,35], without which cells show
morphological and growth defects, as well as aberrant protein secretion [34,35]. Mutants with
inactive sagA or scaH genes show similar cell architecture, growth and cell division to wildtype
S. aureus [34,35]. Mutants lacking up to three of the four glucosaminidases are viable [35].
While much is known about the structure of S. aureus PG grown in vitro [40], there is, as of
yet, no data on the structure during an infection in any organism. Several studies have utilised
“pseudo in vivo” conditions to mimic the complex environment of an infection. Staphylococcus
epidermidis PG isolated from an in vitro biofilm in platelet concentrates show substitutions in
the pentaglycine bridge, with glycine being substituted for serine or alanine residues, as well as
increased O-acetylation, providing resistance to lysostaphin and lysozyme [14,41].
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Here we further developed reverse phase high performance liquid chromatography
(RP-HPLC) coupled to mass spectrometry (MS) methodologies, with MS/MS allowing the
identification of a muropeptide based on its mass and fragmentation pattern [42], to deter-
mine the PG composition during a murine sepsis model of infection [4,18]. This provides the
first data of PG structure during an active infection revealing the impact of cell wall homeo-
static mechanisms on S. aureus virulence.
Results
Morphological analysis of S. aureus during infection
The murine sepsis model of infection [4,18] was used to derive in vivo grown S. aureus cells.
This model has an organ tropism that leads to kidney abscesses, providing a concentration of
bacterial cells for analysis [4]. 72 hours post infection (hpi) kidneys were harvested and
homogenised. For transmission electron microscopy (TEM), bacteria were recovered from the
homogenate by centrifugation, processed for analysis and compared to in vitro derived cells.
TEM was performed on three independent S. aureus NewHG kanR exponential phase (OD600
of 0.6) or stationary phase (8 hours of growth, OD600 of around 9–10) cultures (Figs 1A, 1B,
S1A and S1B) and two independent S. aureus NewHG kanR samples recovered from murine
kidneys (Figs 1C and S1C). Uninfected kidneys were also processed as a control (S1D Fig).
Initially, cell area was compared (Fig 1D). S. aureus cells grown to exponential phase have a
significantly greater cell area (0.45 μm2 ± 0.09 μm2) than those cultured to stationary phase
(0.37 μm2 ± 0.06 μm2) in TSB (p< 0.0001), as has been previously shown [43]. S. aureus cells
recovered from murine kidneys also show a significant reduction in area (0.35 μm2 ± 0.1 μm2)
compared to both exponential and stationary phase cells (p< 0.0001 and p = 0.0364,
respectively).
The S. aureus cell wall forms a distinct layer around the periphery of the cell (Fig 1E). Expo-
nential phase cells have a significantly thinner cell wall (22.7 nm ± 2.4 nm) than both station-
ary phase cells (25.1 nm ± 4.5 nm, p< 0.0001) and those from kidneys (25.3 nm ± 4.3 nm,
p< 0.0001). No significant difference between cell wall thickness of stationary phase cells or
cells recovered from kidneys could be detected (p = 0.9611).
The above analysis reveals that in vivo, within 3-day infected kidneys, the bacteria have a
morphology reminiscent of quiescent cells [43]. To determine if active cell division is taking
place the percentage of S. aureus cells possessing, or lacking, incomplete or complete septa was
determined for each growth condition (Fig 1F). A significantly greater proportion of stationary
phase cells had no septa compared to both exponential phase and in vivo derived cells
(p< 0.0001), the latter 2 groups not showing a significant difference (p = 0.5429), suggesting
that in vivo cells divide more often or slower. However, exponential phase cells have a signifi-
cantly greater proportion with incomplete septa than both stationary phase and in vivo cells
(p< 0.0001 and p = 0.0007) and kidney derived cells (p = 0.0007), the latter 2 groups not
showing a significant difference (p = 0.2617). In vivo there was a significantly greater propor-
tion of undivided cells with a complete septum than exponential phase (p = 0.0057) and sta-
tionary phase cells (p = 0.0034), the latter 2 groups did not show a significant difference
(p = 0.9548). All together these data point to possible alterations in cell wall structure and
dynamics in vivo, with thicker cell walls and reduced cell separation after septation.
Infection-associated S. aureus PG structural analysis
Morphological analysis revealed that S. aureus recovered from murine kidneys resemble quies-
cent cells, being smaller with thickened cell walls (Fig 1). The composition of the PG was deter-
mined by muropeptide analysis [42,44,45], comparing in vivo derived PG to that from in vitro
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grown exponential and stationary phase cells (Fig 2A and 2B). The traces show the identifica-
tion of monomeric muropeptide species (muropeptides 3, 4, 5, 10, 12 and 14), dimeric species
(muropeptides 17, 18, 21 and 24) and higher crosslinked trimeric (muropeptide 28), tetrameric
(muropeptide 29) and pentameric (muropeptides 33 and 34) species as described in S3 Table.
Kidney homogenates from 2 independent experiments (10 mice in each experiment, total-
ling 20 kidneys) were combined and PG was collected and purified, which equated to the
material from 1.03 x 108 and 9.3 x 107 CFU, respectively. After purification, the remaining pel-
let appeared grey rather than the white colour observed from in vitro samples. Further SDS
washes or pronase treatments did not alter the pellet. However, the presence of the host kidney
Fig 1. TEM analysis of S. aureusNewHG grown in vitro and in vivo. Thin sections of chemically fixed S. aureus NewHG kanR (SJF 3680) cultured
in TSB to (A) exponential or (B) stationary phase or (C) recovered frommurine kidneys (72 hpi). Scale bars (black line) represent500 nm. (D) Cell
area of NewHG kanR cultured in TSB to exponential phase (3 independent repeats totalling 411 cells), in TSB to stationary phase (3 independent
repeats totalling 320 cells) or recovered frommurine kidneys (72 hpi) (2 independent repeats totalling 180 cells). Results analysed using a one-way
ANOVAwith multiple comparisons (� p = 0.0364, ���� p< 0.0001). (E) Average cell wall thickness of NewHG kanR cultured in TSB to exponential
phase (black lines, 3 independent repeats totalling 367 cells), in TSB to stationary phase (blue lines, 3 independent repeats totalling 256 cells) or
recovered frommurine kidneys (72 hpi) (red lines, 2 independent repeats totalling 104 cells). Results analysed using a one-way ANOVA with
multiple comparisons (���� p< 0.0001). Box and whiskers for (D) and (E) represent mean, lower and upper quartiles, and range respectively. (F)
Normalised percentage of NewHG kanR that show no, incomplete or a completed septum. Normalised proportions were compared using a two-way
ANOVAwith multiple comparisons with Tukey’s correction (no septa ��� p = 0.0001, ���� p< 0.0001; incomplete septa ��� p = 0.0007, ����
p< 0.0001; complete septa �� p = 0.0034 and 0.0057). Error bars represent the standard deviation of the mean. (Exponential phase cultured in TSB–
black bars, stationary phase cultured in TSB–blue bars, cells recovered frommurine kidney homogenate–red bars).
https://doi.org/10.1371/journal.ppat.1009468.g001
PLOS PATHOGENS The S. aureus cell wall and virulence
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009468 March 31, 2021 5 / 30
derived material did not prevent mutanolysin digestion of the PG. A representative muropep-
tide profile of PG from S. aureus NewHG purified from murine kidneys is shown in Fig 2C.
Monomeric, dimeric, trimeric, and tetrameric muropeptide species were identified, which all
corresponded to those found from in vitro growth (S4A–S4H Table).
The area of each identified UV-absorbance peak was calculated, expressed as a percentage
of the total area of all identified peaks and grouped based on the level of crosslinking (Fig 2D),
as derived from monomeric (Fig 2E), dimeric (Fig 2F) and oligomeric (Fig 2G) material. Sig-
nificantly more monomeric muropeptides are found in stationary phase and in vivo samples
(p = 0.0180 and p = 0.0081, respectively) than exponential phase cells, the former 2 groups not
showing a significant difference (p = 0.8734). No differences in dimer levels were found. Sig-
nificantly fewer oligomeric species were present in stationary phase and in vivo samples com-
pared to exponential phase cells (p = 0.0101 and p = 0.0002, respectively). The former 2 groups
did not show a significant difference in oligomer levels (p = 0.0691). An increase in monomers
Fig 2. Analysis of S. aureusmuropeptide profiles in different growth conditions. Representative muropeptide profiles of NewHG kanR (SJF 3680) cultured in TSB
in (A) exponential phase (OD600 ~0.6) or (B) stationary phase (OD600 ~9). Muropeptides have been labelled after being identified by MS (S1 Table) (C)
Representative muropeptide profile of NewHG kanR (SJF 3680) recovered frommurine kidneys 72 hpi. Identified muropeptides are labelled using muropeptide
numbers from S3 Table. (D) Area of eluted identified UV-absorbing peaks shown as a percentage of the total of all identified peaks grouped based on cross-linking
(exponential phase TSB—black bars n = 3, stationary phase TSB–blue bars n = 3, NewHG kanR recovered frommurine kidney–red bars, n = 2 independent
experiments, each consisting of 10 mice, error bars represent the standard deviation of the mean). A two-way ANOVA with Sidak’s multiple comparison post-test
was used to compare abundance of each muropeptide species (monomers � p = 0.0108, �� p = 0.0081; oligomers � p = 0.0101, ��� p = 0.0002). Representative generic
muropeptide structures, (E)monomeric, (F) dimeric and (G) oligomeric.
https://doi.org/10.1371/journal.ppat.1009468.g002
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and a concomitant decrease in oligomers evidences a decrease in PG cross-linking as cells
enter stationary phase or are in vivo derived.
The role of the PG synthase PBP4 in infection
Reduced in vivo oligomeric PG suggests a downregulation of crosslinking activity, which PBP4
is known to be responsible for in vitro [26], thus the role of PBP4 in infection was investigated.
To determine the role of PG dynamics in infection, both the zebrafish and murine sepsis mod-
els were used. Comparing NewHG pbp4::ery (SJF 5103)to its parent NewHG in the zebrafish
model of infection revealed no significant difference in larval mortality rate (S2A Fig). In the
murine sepsis model, using an inoculum of 5 x 106 or 1 x 107 CFU/mouse no significant differ-
ences were observed for weight loss or kidney CFU when comparing both strains at the differ-
ent inocula (Figs 3A and S2B). The pbp4 strain gave a significantly greater recovery of bacteria
from the liver, 3 days post infection (Figs 3B and S2C: p = 0.0051 and p = 0.0294 respectively),
suggesting that S. aureus pbp4 mutant is fitter in the murine liver than the parental strain. In
the murine sepsis model bacteria are initially captured by Kupffer cells in the liver, from
whence kidney abscesses are seeded [4]. During this process, an immunological bottleneck
occurs in the phagocytes that results in clonal expansion. To determine if the increased liver
CFU associated with the pbp4 mutation is due to a bypass of the immune bottleneck, matched
pbp4 strains, isogenic apart for antibiotic resistance markers (to allow selection), were created.
Mice were injected with a 1:1 ratio of marked strains (total 7 x 106 CFU) and infection dynam-
ics monitored over time (S2 Fig). As expected, after infection the bacteria are found primarily
in the liver and spleen (S2G and S2J Fig). Within 24 hrs CFU begin to increase in the kidneys,
associated with the formation of characteristic abscesses (S2H and S2I Fig), whilst numbers
remain low in the lungs and heart throughout (S2K and S2L Fig). Clonal expansion is observed
by an alteration in the ratio of the matched strains over time (S2M–S2R Fig), as measured by
population evenness, from evenly mixed populations to those dominated by a single clone [4].
By 72 hpi predominantly clonal organs are observed (single colour dominating; S2E and S2F
Fig). Linear regression revealed a statistically significant decrease in population evenness in
the liver for both pbp4 (p = 0.0036, F = 11.17, R2 = 0.3829) and its parent (p = 0.0448,
F = 4.795, R2 = 0.2422) and no difference between the 2 strains (p = 0.6077, F = 0.2686) dem-
onstrating both strains pass through the immune bottleneck similarly. Overall, this suggests
that S. aureus pbp4 mutant is fitter in the murine liver than the parental strain.
To confirm the proposed fitness phenomenon, 20 mice were injected with a 1:1 ratio (total-
ling 7 x 106 CFU) of NewHG and NewHG pbp4. Mice were infected for a period of 72 hours
before being culled and organs harvested. The total number, and ratio of each strain, recovered
from each organ was calculated (Fig 3D). The pie charts show the ratio of NewHG (red) to
NewHG pbp4 (blue), with the central number indicating the log total number of bacteria
recovered, with most organs dominated by a single strain at 72 hpi.
To determine if the ratios of the recovered strains are significantly different from the infec-
tious dose (1:1), the relative fitness of NewHG pbp4 was calculated using the formula w =
x2(1-x1) /x1(1-x2) (where w = relative fitness, x1 = starting mutant proportion and x2 = ending
mutant proportion) [46]. This gives a numerical value for the relative fitness of NewHG pbp4,
where a value of 1 indicates an equal fitness between strains, a value greater than 1 shows a
greater fitness for NewHG pbp4, and a value less than 1 a greater relative fitness for NewHG
[46]. These values were plotted for each mouse organ (Fig 3E–3J). In no organ did the parental
strain predominate. On the contrary, in livers (p = 0.0105), right kidneys (p = 0.0327) and
spleen (p = 0.0476) there was a significantly higher proportion of pbp4, compared to its parent.
Thus, the presence of PBP4, that is responsible for PG crosslinking asserts a fitness cost in vivo,
PLOS PATHOGENS The S. aureus cell wall and virulence
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in particular in the liver. This matches the biochemical observation of decreased oligomeric
PG in vivo. However, virulence factors can also be niche specific, as pbp4 has been shown to
have a positive role in bone infection [47]. The decrease in crosslinking associated with loss of
pbp4 (with a higher proportion of monomers to oligomers) could also result in a greater activa-
tion of the innate immune system via induction of NOD2 [48], or NLRP3 activation [29].
The role of the PG hydrolase SagB in infection
In the systemic zebrafish model of infection, a sagB mutation resulted in significant attenua-
tion in both the NewHG and SH1000 strain backgrounds (S3A and S3B Fig). In this model
bacteria are phagocytosed after infection, where subsequent emergence of bacteria leads to
clonal lesion formation [49,50]. This model allows pathogen population dynamics to be deter-
mined to assess at what stage sagB is attenuated. At specified time points during ongoing infec-
tion, five infected living zebrafish larvae (and all dead) were collected and homogenised, after
bacterial CFU was determined. For NewHG and SH1000 controls, with an infectious dose that
kills approximately 50% of larvae, the bacterial numbers either remain similar to the inoculum
or increase up to approximately 106 CFU with concomitant death (S3C and S3E Fig). The oth-
erwise isogenic sagB strains show similar kinetics but with less hosts succumbing and
increased bacterial clearance (S3D and S3F Fig).
The attenuation of NewHG sagB was further investigated in the murine sepsis model of
infection. Mice infected with NewHG sagB show significantly less weight loss that those
infected with the parental strain (Fig 4A, p = 0.0005) and less S. aureus was recovered from the
livers (Fig 4B, p = 0.0178) and kidneys (Fig 4C, p = 0.0178). This suggests that in murine infec-
tion, loss of SagB reduced bacterial fitness.
Fig 3. The role of PBP4 in S. aureus virulence.Mice (n = 10) were injected with approximately 5x106 CFU S. aureus NewHG kanR (WT, SJF 3680) or
NewHG pbp4::ery (SJF 5103). (A)Weight loss 72 hpi and CFUs recovered from (B) livers, (C) kidneys were determined. Groups were compared using a
Mann-Whitney U test (NewHG kanR–black circles, NewHG pbp4::ery blue squares) (�� p = 0.0051, � p = 0.0410). (D)Mice (n = 20) were injected with a
1:1 ratio (totalling 7 x 106 CFU) of NewHG kanR (SJF 3680, red) and NewHG pbp4::ery (SJF 5103, blue). 72 hpi mice were culled and CFU ratios within
organs were determined. The number in each pie chart represents the log total number of bacteria recovered (i.e. 106 CFU = 6). Mice 9 and 12 were
culled at 54 hpi due to severity limits but are included in the analysis. Mouse 18 was found dead at 72 hpi and is excluded from analysis. The relative
fitness of NewHG pbp4::ery (SJF 5103) against NewHG kanR (SJF 3680) was calculated using the formula w ¼
x2ð1 x1 Þ
x1ð1 x2 Þ
(where w = relative fitness, X1 =
starting mutant proportion and X2 = ending mutant proportion). This was calculated for the (E) liver (
� p = 0.0105), (F) left kidney (p = 0.3258), (G)
right kidney (� p = 0.0327), (H) spleen (� p = 0.0476), (I) lungs (p = 0.3396) and (J) heart (p = 0.43275). Line on graph depicts the median. Statistical
significance was determined using a one sample Wilcoxon signed rank test, comparing the results to a theoretical median of 1, which would indicate an
equal fitness between the strains.
https://doi.org/10.1371/journal.ppat.1009468.g003
Fig 4. The role of SagB in S. aureus virulence. Approximately 1 x 107 CFU of S. aureus NewHG kanR (SJF 3680) or NewHG sagB::kan (SJF 4912)
were injected intravenously into mice (n = 10). (A)Weight loss 72 hpi (p = 0.0005), (B) liver CFU (p = 0.0178) and (C) kidney CFU (p = 0.0368).
Groups were compared using a Mann-Whitney U test (NewHG kanR–black circles, NewHG sagB red squares).
https://doi.org/10.1371/journal.ppat.1009468.g004
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The role of PGmetabolism in murine macrophage interaction
In the murine sepsis model, Kupffer cells are primary gatekeepers to capture and control S.
aureus circulating in the blood [4,51]. To determine if the roles in pathogenesis for PBP4 and
SagB are associated with in vivo macrophage interactions, clodronate [52] was used to ablate
these phagocytes. Clodronate treated mice are more susceptible to infection, so a lower inocu-
lum of 1 x 105 CFUNewHG, pbp4 or sagBwas used, with mice being injected with empty (con-
trol) or clodronate containing liposomes (Fig 5). With this low inoculum the vehicle liposome
mice were able to control infection, maintain weight, and had residual bacterial numbers in
organs, with no significant differences between the parent and mutants. However, clodronate
led to a severe infection with the parental NewHG strain, with substantial weight loss and high
CFU in both liver and kidneys. Loss of PBP4 had no effect on virulence (Fig 5A–5D) in the clo-
dronate treated mice, alluding to a role for macrophages in the observed increase in recovery
of pbp4 in untreated mice (Fig 3B). Conversely the sagB mutant was still attenuated as mea-
sured by weight loss (Fig 5E, p = 0.0254) and CFU in the liver (Fig 5F, p = 0.0243), kidneys
(Fig 5G, p = 0.0030) and spleen (Fig 5H, p = 0.0196). Therefore, macrophages can at most only
be part of the reason why sagB is attenuated.
The role of PGmetabolism in human macrophage interaction
To further determine the role of PG metabolic components in host interaction, human mac-
rophages were used. Monocyte derived macrophages (MDM, 2 x 105) were infected with 1 x
106 CFU NewHG pbp4 or NewHG (multiplicity of infection (MOI) of 5) for 4 hours. At 4.5
hpi there is no significant difference in the NewHG kanR or NewHG pbp4 CFU recovered
from lysed macrophages (Fig 5I). However, at 5 hpi, significantly more NewHG pbp4 are
recovered from macrophages than NewHG (p = 0.0008). At 5.5 and 6.5 hpi no differences
were observed in the recovery of internalised NewHG or NewHG pbp4. This suggests that
NewHG pbp4 are more able to survive initial macrophage killing but succumb later. How-
ever, as CFU outcome is a product of both bacterial proliferation and survival, it is possible
that the pbp4 mutant has an initial intracellular growth advantage over the wildtype strain.
The survival of NewHG pbp4 was also investigated in neutrophils, where no difference in
uptake (S2S Fig) or CFU recovered from neutrophils (S2T Fig) was found compared to the
parental strain.
The role of SagB in MDM interactions was also tested as above (Fig 5J). The intracellular
NewHG sagB CFU recovered at 5 (p = 0.0250), 5.5 (p = 0.0075) and 6 hpi (p = 0.0003) are all
significantly lower than those recovered for NewHG, demonstrating NewHG sagB is less able
to survive within host macrophages. However, reduced intracellular proliferation could also be
the cause of fewer CFUs being recovered for the NewHG sagB.
Role of PGmetabolism components in augmentation of pathogenesis
Recently, the phenomenon of augmentation of infection has been described, whereby co-inoc-
ulation of S. aureus with commensal organisms, or cell wall PG, results in the ability of a much
lower inoculum to cause disease [18]. Augmentation occurs within Kupffer cells resulting in
increased S. aureus survival and subsequent proliferation [18]. Given the ability of PG to elicit
augmentation, we determined the role of the metabolic components. Purified PG could be
contaminated with lipoproteins, which are known to be immunobiologically active [53]. How-
ever, PG isolated and purified from an lgt mutant (which has no lipoprotein) has previously
been shown to augment infection [18]. Mice were injected with a low dose (1 x 106 CFU)
NewHG or NewHG pbp4, with or without the addition of 250 μg purified S. aureus NewHG
PG. Augmentation of NewHG resulted in more weight loss (p = 0.0079) and increased CFU in
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the liver (p = 0.0079) for both NewHG and its pbp4 derivative (S4 Fig). There was a significant
increase in CFU recovered from NewHG pbp4 infected livers, compared to wildtype infected,
but this was lost upon augmentation (S4 Fig; p = 0.0397 and 0.2857, respectively).
Both NewHG and its sagB derivative demonstrated augmentation in terms of weight loss
(S4 Fig; p = 0.0079 and 0.0159, respectively), however, only NewHG liver CFUs increased
when augmented with PG (p = 0.0079 and 0.0952, respectively). These data suggest that nei-
ther the activities of SagB or PBP4 are required for augmentation to occur.
Fig 5. The role of peptidoglycan metabolism components and macrophages in S. aureus host-pathogen interactions.Mice (n = 10) were injected with
approximately 1 x 105 CFU of NewHG kanR (SJF 3680), NewHG pbp4::ery (SJF 5103) or NewHG sagB::kan (SJF 4912) 24 hours post treatment with either empty
liposomes or clodronate containing liposomes. 72 hpi, mice were sacrificed and the weight change (A, E, � p = 0.0254) and liver (B, F, � p = 0.0243), kidney (C, G, ��
p = 0.0030) and spleen (D, H, � p = 0.0196) CFU were determined. (NewHG kanR–black circles, NewHG pbp4::ery—blue squares, NewHG sagB::kan- red squares).
One mouse in the NewHG kanR clodronate treated group and the NewHG pbp4 clodronate treated groups was culled at 48 hpi due to reaching severity limits and
have been excluded from analysis. MDMs were infected with S. aureus NewHG kanR (SJF 3680, black bars), (I)NewHG pbp4::ery (SJF 5103, blue bars) or (J) or
NewHG sagB::kan (SJF 4912, red bars) at a MOI of 5 (1 x 106 CFU) for 4 hours before being treated with gentamycin for 0.5 hours to kill extracellular bacteria.
MDMs were lysed at specific time points and intracellular bacterial numbers were determined. Paired two-tailed t-tests were used to compare between the strain
CFU at subsequent time points. (For (I) ��� p = 0.0008 and for (J) � p = 0.0250, �� p = 0.0075, ��� p = 0.0003) Error bars show ±SD. (n = 3, each consisting of 2 intra-
assay repeats).
https://doi.org/10.1371/journal.ppat.1009468.g005
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The combined role of PG synthases and hydrolases in S. aureus virulence
Loss of PBP4 resulted in increased S. aureus fitness in the livers of mice, while a loss of SagB
resulted in decreased virulence. The combined roles of SagB and PBP4 was therefore tested. In
the zebrafish model of infection, sagB was attenuated compared to NewHG (p = 0.0157),
whereas pbp4 and pbp4 sagB were not (p = 0.2002 and 0.1602, respectively). NewHG and oth-
erwise isogenic pbp4, sagB and pbp4 sagB were compared in the murine sepsis model (Fig 6).
Loss of PBP4 led to increased CFU in the liver (p = 0.0119) and sagB decreased kidney num-
bers (p = 0.0053), compared to NewHG as expected. NewHG pbp4 sagB did not show a signifi-
cant difference in terms of weight loss or organ CFU compared to NewHG (Figs 6 and S5).
Using Fisher’s test to compare the ratios of infected and non-infected livers (Fig 6C) between
strains, it was found that there were significant differences between the ratios of uninfected
and infected livers between sagB and pbp4 (p = 0.0108) and pbp4 and the pbp4 sagB mutants
(p = 0.0325). No significant differences were found between groups in the kidneys using this
Fig 6. Analysis of growth and virulence of NewHG sagB pbp4. (A) Approximately 1500 CFU of bacteria (mutant or
wildtype) was injected into the circulation valley of LWT zebrafish embryos around 30 hpf. A survival curve was
produced comparing the virulence of parental NewHG (SJF 3663, black line) to: NewHG sagB::kan (SJF 4912, red line),
NewHG pbp4::ery (SJF 5103, blue line) and NewHG sagB::kan pbp4::ery (SJF 5147, purple line). (3 repeats, n>20, �
p = 0.0157). Mice (n = 10) were injected intravenously with approximately 1x107 CFU S. aureus NewHG kanR (WT,
SJF 3680), NewHG sagB::kan (SJF 4912), NewHG pbp4::ery (SJF 5103) or NewHG sagB::kan pbp4::ery (SJF 5147). (B)
Weight loss 72 hpi and CFUs recovered from (C) livers (� p = 0.0119) and (D) kidneys (� p = 0.0055). Groups were
compared using a Mann-Whitney U test (NewHG kanR–black circles, NewHG sagB::kan–red squares, NewHG pbp4::
ery blue diamonds, NewHG sagB::kan pbp4::ery–purple triangles).
https://doi.org/10.1371/journal.ppat.1009468.g006
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analysis. This suggests that the combination of the two mutations result in a compensatory
effect on virulence.
The role of the glucosaminidases in virulence
SagB is a member of a family of 4 putative glucosaminidases (SagB, Atl, SagA, ScaH) encoded
on the S. aureus chromosome [34,35]. As a sagB mutant was found to be attenuated in both
the zebrafish and murine models of infection, it was hypothesised that other putative glucosa-
minidases of S. aureus (Atl, SagA and ScaH) may also play a role in infection. The SH1000
background was used for this part of the study as the range of mutants were available and had
been previously characterised in terms of biochemistry and physiology [35]. For the single
mutants (atl, sagA, scaH) no differences in pathogenesis were observed in the zebrafish S.
aureus infection (S6 Fig). It is known that Atl is required for cell separation [35,36,54] and so a
sonicated inoculum was used to ensure an accurate CFU was administered. The loss of SagA
or ScaH did not affect cell separation alone (S6 Fig). Given the functional redundancy previ-
ously observed for PG hydrolases a series of double and a triple mutant were tested. Multiple
mutant strains containing the atl mutation all showed a clustering phenotype during growth
(S6 Fig) and by flow cytometry (Fig 7E), which could be reversed by sonication. To test viru-
lence of the strains, the equivalent of 1300 bacteria were injected into zebrafish embryos (Fig
7). 400 particles of SH1000 atl sagA, 300 particles of SH1000 atl scaH or 1300 particles SH1000
sagA scaH, all consisting of approximately 1300 bacteria, were injected into embryos and com-
pared to sonicated particles and SH1000. Embryos injected with unsonicated SH1000 atl sagA
or atl scaH showed significantly greater survival than those injected with SH1000 (both
p< 0.0001) and full virulence of the inoculum was restored by sonication prior to injection.
Both untreated and sonicated SH1000 sagA scaH showed no difference in virulence compared
to SH1000 in the zebrafish model of infection (Fig 7C). The triple SH1000 atl sagA scaH
mutant also has a cell separation defect and attenuated virulence that can be ameliorated by
sonication (Figs 7 and S7). Thus, the number or size of cell particles inoculated has a profound
effect on infection outcome.
The virulence of SH1000 atl sagA scaH was further tested in the mouse sepsis model of
infection. SH1000 kanR was used as the control [55] to allow selection of S. aureus from organ
homogenates. Mice were injected with unsonicated or sonicated SH1000 or SH1000 atl sagA
scaH, of known particle and CFU number. Mice were injected with 1.6 x 107 CFU in 1.5 x 107
particles of unsonicated SH1000, or 1.6 x 107 CFU of sonicated bacteria. 1.4 x 107 bacteria in
5.6 x 106 particles of unsonicated SH1000 atl sagA scaH or 1.5 x 107 CFU of sonicated bacteria
were used. As opposed to the zebrafish model, using a sonicated versus an untreated inoculum
did not affect the outcome in terms of weight loss or organ CFU for SH1000 or atl sagA scaH.
However, the unsonicated triple mutant is attenuated in terms of weight loss (p = 0.0314) and
liver CFU (p = 0.0014) compared to SH1000 (Fig 7). Sonication of organs after harvesting, to
disrupt potential bacterial clusters, did not significantly alter organ CFU (S7 Fig). Thus,
SH1000 atl sagA scaH is attenuated in the murine sepsis model and, unlike in the zebrafish
model, sonication to disperse clusters has no impact on virulence in this system.
To determine if the alterations in PG structure and cell clustering effect the augmentation
of S. aureus infection by PG the pathogenesis of atl sagA scaH was determined in the presence
of PG from SH1000 or atl sagA scaH (S7 Fig). As atl sagA scaH is attenuated, an inoculum of 1
x 107 CFU of sonicated SH1000 atl sagA scaH was used for augmentation. Experiments to
examine augmentation were carried out using 250 μg of PG from SH1000 or SH1000 atl sagA
scaH. Successful augmentation occurred with both types of PG resulting in significant weight
loss and increase in CFU in the livers and kidneys (S7 Fig; all p< 0.05). For spleens, lungs and
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hearts, no significant difference between recovered CFU could be seen between groups (S7
Fig). This demonstrates that PG of diverse origins can augment pathogenesis [18] and that
produced from atl sagA scaH was still capable of enhancing infection.
Discussion
We report the first PG structure from bacteria obtained during an infection. The muropeptide
profile, paired with TEM analysis, has helped to elucidate the structure of the S. aureus cell
wall during disease. Defining host-pathogen interactions increases understanding of the infec-
tion process, thereby providing new information for developing treatment, especially impor-
tant in the ever-approaching post-antibiotic era. Previous research has determined that the
growth phase of S. aureus influences the immune response of infected dendritic cells, which is
Fig 7. Role of putative glucosaminidases in S. aureus growth and virulence. Survival curves comparing the virulence of 1300 CFU parental NewHG (SJF
3663, black lines) to (A) 400 particles unsonicated SH1000 atl sagA (SJF 5261, solid green line) consisting of 1300 bacteria (when sonicated) or approximately
1300 CFU of sonicated SH1000 atl sagA (broken green line). (B) 300 particles of unsonicated SH1000 atl scaH (SJF 5262, solid orange line) consisting of 1300
bacteria (after sonication) or 1300 CFU sonicated SH1000 atl scaH (broken orange line). (C) 1300 CFU unsonicated SH1000 sagA scaH (SJF 5217, solid purple
line, sonication did not change CFU) or 1300 CFU sonicated SH1000 sagA scaH. (D) 100 particles of unsonicated SH1000 atl sagA scaH (consisting of 1500
bacteria, solid brown line), 1500 CFU of sonicated SH1000 atl sagA scaH (broken brown line). (A-D each consist of 3 repeats, n>20, ���� p< 0.0001). (E)
Comparison of the median FSC light values of parental SH1000 (unsonicated white bar, sonicated black and white bar), SH1000 atl sagA (unsonicated green
bar, sonicated green and white bar), SH1000 atl scaH (unsonicated orange bar, sonicated orange and white bar) SH1000 sagA scaH (unsonicated purple bar,
sonicated purple and white bar) and SH1000 atl sagA scaH (unsonicated brown bar, sonicated brown and purple bar). (n = 3, ���� p< 0.0001). Error bars show
±SD, FSC values were compared using a one-way ANOVA with Dunnet’s multiple comparison test. (F-G) S. aureus SH1000 kanR (SJF 3674) or SH1000 atl sagA
scaH (SJF 4611) were injected intravenously into mice (n = 10). Approximately 1 x 107 bacteria were injected in unsonicated and sonicated groups. 1 x 107
bacteria in 5 x 106 particles of unsonicated SH1000 atl sagA scaH was injected (sonication had no effect on SH1000 kanR). (F)Weight loss 72 hpi (� p = 0.0314),
(G) liver CFU (�� p = 0.0014, ��� p = 0.0003) and (H) kidney CFU (�� p = 0.0096) were determined. Groups were compared using a Kruskal-Wallis test with
multiple comparisons (Unsonicated SH1000 kanR–black circles, sonicated SH1000 kanR–open black circles, unsonicated SH1000 atl sagA scaH—brown squares
and sonicated SH1000 atl sagA scaH–open brown squares). Sonication was for 20 seconds at an amplitude of 5 microns when required.
https://doi.org/10.1371/journal.ppat.1009468.g007
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also influenced by exogenous PG [56]. Knowing the structure and composition of PG during
an infection could therefore provide more detail on S. aureus interactions with the host
immune system.
We show that S. aureus has reduced PG crosslinking during an infection than when cul-
tured in vitro. Many surface proteins are required in abscess formation [57,58], which are
bound to the terminal glycine in the pentapeptide bridge [59]. The observed reduction in
crosslinking in PG recovered from infected kidneys could be due to glycine bridges being used
to anchor cell surface proteins required for abscess formation, at low growth rates, permitting
survival and pathogenesis in the host, rather than crosslinking PG. A reduced muropeptide
diversity was presented in this study (Fig 2 and S4 Table), suggesting that PG from S. aureus
has less complexity and crosslinking during an infection. It has been hypothesised that in S.
epidermidis PG synthesis is reduced when exposed to human platelets, creating a less complex
PG structure [41]. This allows energy to be used in other processes, allowing proliferation of
bacteria in a harsh, restrictive environment such as infection [41]. Salmonella enterica serovar
Typhimurium cultured within human epithelial cells possesses a unique PG structure, with a
reduction in glycine containing muropeptides and a decrease in crosslinking [60]. The meth-
odology of our study did not allow the detection of O-acetylated muropeptides, which may
change in abundance during infection [13,14].
During infection, S. aureus is likely to be in a state resembling stationary phase (Fig 2). The
PG structure of S. aureus is influenced by nutrient availability during growth, and this is the
likely cause for the reduced PG crosslinking. As cells reach stationary phase glycine depletes as
it is used for protein and cell wall production [11]. This coincides with a thickening of the cell
wall and the production of irregular septa with an increased number of non-crosslinked side
chains [11]. These changes occur in the newly synthesised PG rather than a modification to
existing PG [11]. In a S. aureus biofilm, non-crosslinked pentaglycine bridges are used as
attachment sites for proteins which are less abundant in planktonic culture [61]. S. aureus cells
propagate in diverse environments and in the host with each organ provides a different nutri-
ent and immunological repertoire [62], which could result in differing PG structures during
an infection. Bacteria grow rapidly once in a niche, and quickly run out of resources, with the
abscesses within the kidney being self-limiting [4]. While within macrophages, S. aureus relies
on nutrients to be delivered from the extracellular milieu of the host [63]. A reduction in cell
size has previously been found in viable S. aureus cells undergoing starvation in vitro [43], sug-
gesting a change in metabolism and growth phase may be the reason for the reduction in cell
size and increased cell wall thickness observed in our study. S. aureus has also been observed
to have thicker cell wall material when intracellular within human or mouse osteoblasts [64].
The role of PG metabolism in virulence was also investigated within our study due to the
observed changes in cell wall structure (thicker cell walls) and muropeptide profile (less cross-
linked species) in S. aureus recovered from an infection. A pbp4 mutant (with reduced PG
crosslinking) demonstrates greater colonisation of mouse livers in the murine sepsis model of
(Fig 3). This complements previous findings that a pbp4 mutant causes larger skin lesions in
infected mice, which was suggested to be caused by an increase in production of IL-1β [29].
Similarly, inactivation of the ClpXP protease, which results in thicker cell walls and increased
peptidoglycan cross-linking [65], resulted in a less expression of IL-1β in mouse bone marrow-
derived macrophages [29]. In a murine model for implant-associated osteomyelitis it was
found that the loss of pbp4 resulted in no change in bacterial loads and attenuation in regards
to bone loss [47]. Our study shows an increase in liver CFUs but with no change in weight loss
in mice, suggesting no overall increase in virulence in the pbp4 mutant. Liver phagocytes take
up the majority of free S. aureus in the blood during a murine infection [4], with bacteria
being taken up by Kupffer cells [51]. This suggests that a change in IL-1β production may
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occur during infection dependent on the crosslinking of PG, with reduced PG crosslinking
resulting in greater colonisation in the liver. In a S. aureus oatA mutant which does not have
O-acetylated PG, the PG can be degraded by lysozyme which results in IL-1β induction [66],
suggesting that PG crosslinking and degradability is important in pathogenesis and the host
response. A hypothesised change in PG crosslinking may also facilitate colonisation of livers
through resistance to macrophage killing (Fig 5I), which could also be explained by changed
induction of macrophage antimicrobial products, or a reduction in the secretion of proinflam-
matory cytokines [29].
The observed in vivo increase in S. aureus cell wall thickness and proportion of cells which
fail to separate after septation (Fig 1) suggests an alteration in PG hydrolase activity compared
to in vitro growing cells. The loss of the major glucosaminidase SagB has recently been shown
to lead to thinner cell walls [40] and thus SagB was hypothesised to be involved in the
increased cell wall thickness and have a role in disease. Investigation into the glucosaminidases
which revealed different roles for the members of this class of enzymes. A loss of SagB alone
results in attenuation, whereas a combination of the other three (Atl and SagA or ScaH) is
required for attenuation. Understanding the role of PG hydrolases allowed us to discern the
reasons for the triple (Atl, SagA, ScaH) attenuation as these function in cell separation. It has
previously been shown in Enterococcus faecalis that loss of AtlA activity results in long cell
chains and attenuation in the zebrafish model of infection, reversible upon chain disruption
[67]. Our study has shown that in S. aureus the loss of Atl (the major PG hydrolase) activity
alone is not enough to cause attenuation in a zebrafish model of infection (S6C Fig). SagA
and/or ScaH activity must also be inactive to result in attenuation that is reversible on cluster
disruption (Fig 7). However, we have also shown that in a murine model of infection cluster,
disruption does not restore virulence, suggesting that inhibiting S. aureus cell cleavage could
potentially be a promising route for new clinical treatments. This disparity could be due to
there being a greater number of immune bottlenecks in a murine infection compared to zebra-
fish [4], resulting in clusters reforming at different points within the host. The size of bacterial
cells and particles has previously been shown to be important during infection. Uropathogenic
E. coli form filaments by inhibiting septation, resulting in resistance to phagocytosis and
increased survival [68,69]. In Enterococcus faecalis loss of AtlA (PG hydrolase dedicated to sep-
tum cleavage) results in long chains of cells, which are attenuated within zebrafish due to their
susceptibility to phagocytosis [67]. Similarly in Streptococcus pneumoniae infection, increasing
chain length increases the pathogen’s susceptibility to phagocytosis due to increasing comple-
ment deposition [70]. In vitro experiments in alveolar macrophages using polystyrene particles
of different shapes and sizes has shown that particle size influences the completion of phagocy-
tosis, even when the particle has a greater volume than the phagocyte [71]. Particle shape and
the point of contact between the particle and macrophage was found to be more important for
phagocytosis initiation [71]. The formation of clumps reduces the ability of S. aureus to dis-
seminate during an infection, as similarly proposed for E. faecalis [67]. The reduction in dis-
semination and multiple bacteria forming single particles potentially limits the number of
infectious events being initiated. It has been proposed that S. aureus infection dynamics
requires the interaction with phagocytes for infection and dissemination to occur [4]. There-
fore, the lack of dissemination from clustering results in fewer phagocytosis events resulting in
S. aureus infection establishing, and therefore less chance of causing mortality in the zebrafish
model of infection.
While macrophages play a role in the attenuation of sagB mutants, it is not the only cause of
attenuation (Fig 5). The inactivation of sagB has been shown to result in a slight growth defect
and longer glycan chains in PG, resulting in a stiffer cell wall which impairs cells in their ability
to increase in size post division and adopt the correct mature shape [35]. The PG architecture
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of a sagB mutant has recently been shown to take longer to reach maturity [40], and this could
change interactions with the host [56], resulting in attenuation. The change in architecture
could also lead to a change in the surface display of proteins due to a change in the ability to
export proteins across the cell wall. It has already been observed that sagB mutants have an
aberrant protein secretion phenotype [34], which is likely also a cause of attenuation. Secreted
proteins, including those important to virulence, such as: staphylococcal complement inhibi-
tor, staphylococcal superantigen-like protein 1 (SSL1), SSL7, SSL11 and Coa were found in
reduced concentrations in the culture medium when compared to wildtype [34]. The secretion
defect was also found to include the increased secretion of 251 proteins, 90.5% (227 proteins)
of which were predicted to be cytoplasmic [34]. Also previously, disruption of the pentaglycine
crosslink in PG in a Staphylococcus carnosus femB mutant has been shown to result in the
release of cytoplasmic proteins and lipoproteins [72]. Thus the increased secretion of cyto-
plasmic proteins would help to explain both the reduced growth rate in vitro and virulence, as
intracellular proteins erroneously excreted to the extracellular environment cannot perform
their function. Altered release of proteins due to loss of pbp4 or sagB, could account for viru-
lence changes as cytoplasmic proteins such as aldolase and GAPDH have been shown to con-
tribute to virulence in S. aureus [73]. S. aureus sagB mutants have been reported to not show
an altered autolysis phenotype [34], so lysis is not a cause of attenuation.
PG is known to be an important factor in the initiation of infection, being able to augment
S. aureus resulting in an altered disease, with an increased liver colonisation in mice [4,18]. A
reduction in PG crosslinking could result in an increased release of PG turnover products
within the phagosome, augmenting infection [18]. Conversely, the loss of PG hydrolase activ-
ity, such as with SagB, would result in the release of fewer PG turnover products within a pha-
gosome, reducing the augmentation potential of the bacteria. It is also possible that PG
turnover products with different chain lengths and crosslinking may have inherently different
augmenting capabilities, resulting in a change in immune outcome. PG may interact with anti-
microbials produced by phagocytes [74], neutralising them. Different PG structures could
therefore have different capabilities for antimicrobial neutralisation, and therefore different
augmenting capabilities.
Our work paves the way for a fuller understanding of the importance of PG structure in S.
aureus disease and assists the discovery of new ways to control this insidious pathogen.
Materials andmethods
Ethics statement
Murine work was carried out according to UK law in the Animals (Scientific Procedures) Act
1986, under Project License P3BFD6DB9 (Staphylococcus aureus and other pathogens, patho-
genesis to therapy, University of Sheffield Review Board).
S. aureus strains, growth conditions and growth curves
The S. aureus strains used in this study are described in S1 Table. S. aureus transposon mutants
were obtained from the NARSA library (http://www.narsa.net). The transposons from selected
strains were transferred into other S. aureus strains as required byF11 transduction. Genomic
DNA was isolated using Qiagen DNeasy Blood and Tissue kit (Cat no. 69506) in accordance
with manufacturer’s instructions. Prior to DNA extraction 5–10 μl of 5 mg/ml lysostaphin was
added to resuspended S. aureus cells to facilitate lysis. Successful transduction was confirmed
using PCR with the appropriate oligonucleotides listed in S2 Table.
Standard conditions for growth used solid or liquid tryptic soy broth (TSB) supplemented
with erythromycin (5 μg/ml) plus lincomycin (25 μg/ml), kanamycin (50 μg/ml) plus
PLOS PATHOGENS The S. aureus cell wall and virulence
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009468 March 31, 2021 17 / 30
neomycin (25 μg/ml), tetracycline (5 μg/ml) or spectinomycin (100 μg/ml). Bacteria were cul-
tured in a water bath at 37˚C with shaking at 200 rpm to produce a culture at mid-exponential
phase (OD600 0.4–0.8) or stationary phase (OD600 = 8–10) cultures. Direct cell counts were
performed to quantify viable bacterial numbers by serial dilution in sterile PBS. The number
of colony forming units (CFU) were directly counted from the plates after incubation. Growth
curves were performed in triplicate and growth was measured hourly by direct cell counts
and/or OD600measurements. Sonication was performed with a Soniprep 150 Plus bench-top
ultrasonic disintegrator (MSE) with an exponential microprobe (tip diameter of 3 mm), with
400 μl of sample sonicated at an amplitude of 5 microns for 20 seconds on ice.
Transmission electron microscopy (TEM)
After organ CFU had been determined 1 ml of organ homogenate was centrifuged to produce
a pellet (16873 x g, 10 min, room temperature). For in vitro derived samples 1 ml of culture at
the appropriate growth phase was centrifuged (16873 x g, 10 min, room temperature) to pro-
duce a pellet. The samples were then treated for TEM analysis. Briefly, samples were mixed
with 2.5% (w/v) glutaraldehyde and left overnight at 4˚C to fix. Glutaraldehyde was removed
and samples were washed with PBS. Samples were mixed with 2% (w/v) aqueous osmium
tetroxide for 2 hours (at room temperature) for secondary fixation. Excess osmium tetroxide
was removed using two PBS washes. Samples were dehydrated by the addition of incremental
concentrations of ethanol (75% v/v, 95% v/v and 100% (v/v) ethanol) for 15 min each before
being removed and the higher concentration added. Samples were incubated twice with pro-
pylene oxide to complete dehydration. Samples were mixed with a 50% propylene oxide to
50% Epon resin mixture and left overnight at room temperature to allow infiltration of the
sample. The resin was removed, and any remaining propylene oxide was removed by evapora-
tion. Pure Epon resin was added to the sample, which was left for 4 hours, after which the
resin was removed and replaced with fresh pure Epon resin for another 4 hours. Epon resin
was removed and the samples were imbedded in fresh resin. Resin polymerisation was per-
formed at 60˚C for 48–72 hours.
80 nm thin sections of the samples were produced using an Ultracut E Ultramicrotome
(Reichert-Jung) at room temperature. The thin sections were mounted onto 200-square mesh
copper TEM grids (Agar Scientific) already treated with a 1.5% Pyroxylin (w/v, in amyl ace-
tate) film. Mounted sections were stained in 3% (w/v) aqueous uranyl acetate for 30 min and
washed with dH2O. Sections were then stained with Reynold’s lead citrate [75] for 5 min and
washed with dH2O.
Sections were imaged using a FEI Tecnai T12 Spirit Transmission Electron Microscope
operating at 80 kV. Images were recorded using a Gatan Orius SC1000B bottom mounted
CCD camera. TEM images were analysed using Fiji software [76]. Cell area was calculated
using adapted methodology [77]. Two perpendicular measurements were made along the cell,
from the edge of the cell wall to the edge of the cell wall. The measured radii were then used to
calculate the estimated cell area. For cell wall measurements, four equidistant cell wall mea-
surements were made around the cell where the cell wall was clearly defined [78].
Purification of PG
S. aureus cultures of the appropriate growth phase were centrifuged (16873 x g, 10 min, 4˚C)
to harvest cells and resuspended in Tris HCl pH 7.5 containing 2% SDS (w/v) and boiled for
10 min to kill cells and inactivate enzymes before being washed once with dH2O. Boiled cells
were added to lysing matrix tubes containing 0.1 mm silica beads (Lysing Matrix B, MP Bio-
medicals). The cells were sheared 10 times at 6.0 m/s for 30 sec using an MP Biomedicals
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FastPrep 24 Homogeniser, with samples being kept on ice between cycles. Sacculi were sepa-
rated from the lysing matrix by centrifuging for 30 sec at 100 x g and collecting the superna-
tant. Sacculi were harvested from the supernatant and resuspended in 4% (w/v) SDS and
boiled for 30 mins, and then resuspended in 50 mM Tris-HCl pH 7.5 containing 3% SDS (w/
v), 50 mMDTT, 1.25 mM EDTA and boiled for 30 mins. Remaining SDS was removed by
washing the pellet six times in dH2O. Pellets were resuspended in 50 mM Tris HCl pH 7.5 con-
taining 2 mg/ml pronase and incubated for 30 mins at 60˚C. Wall teichoic acids and any other
remaining cell wall polymers were removed by incubating the sacculi in 250 μl 48% (v/v)
hydrofluoric acid (HF) at 4˚C for 48 hours. The purified sacculi were washed in alternating
50mM Tris HCl pH 7.5 and dH2O until the pH was raised to at least 5.0, ending on a dH2O
wash to remove Tris HCl residue. Purified sacculi were harvested by centrifugation and stored
at -20˚C until required.
To produce purified PG (murein) derived from murine infection, individual kidneys were
homogenised in 2 ml PBS using a PreCellys 24-dual (Peqlab) homogeniser. Kidneys (from 10
mice) were pooled from a single mouse experiment that shared a starting inoculum. Insoluble
material was recovered by centrifugation at 16873 x g (Avanti centrifuge, JA 25.50 rotor) and
resuspended in Tris HCl (50mM, pH 7.5) containing 2% SDS (w/v) and boiled for 10 min to
kill cells. Material was washed twice in dH2O, and the pellet resuspended in 10 ml 50 mM Tris
HCl pH 7.5. The mixture was transferred to a Braun Homogeniser bottle containing 50 g of
sterile, acid-washed glass beads and placed on ice. The contents of the bottle were disrupted
using a Braun homogeniser (Braun, Germany). Each bottle was homogenised for 10 x 30 sec,
with 5 min on ice in-between each homogenisation. The beads were separated from the biolog-
ical material with a vacuum sintered glass filter, and the resulting filtrate centrifuged (16873 x
g, 10 min, 4˚C, Avanti centrifuge, JA 25.50 rotor) to recover the bacterial sacculi and residual
kidney matter. The resulting pellet was then purified in the same manner as in vitro derived
material above, using SDS, pronase and HF.
PG digestion, RP-HPLC and mass spectrometry analysis of muropeptides
Purified PG (~2 mg) was resuspended in 90 μl MilliQ water and 10 μl 50 mM ammonium for-
mate buffer (pH 4.8) was added, along with 20 μl cellosyl (kindly provided by Hoechst, Frank-
furt, Germany). The digestion mixture was incubated overnight at 37˚C, 900 rpm in a thermal
shaker (Eppendorf). Cellosyl was inactivated at 100˚C for 10 min, and samples were centri-
fuged at 16873 x g for 10 min, reserving the supernatant. The supernatant was dried using a
speed vac vacuum concentrator (Thermofisher) and resuspended in 25 μl of MilliQ water and
25 μl of 0.5M Ammonium carbonate buffer (pH 9.0). Samples were reduced at room tempera-
ture for 30 min by the addition of tetra methyl ammonium borohydride (around 2 mg). Sam-
ples were acidified using 5% (v/v) formic acid to pH 4.0–4.5, then reduced in volume to
around 30 μl using a speed vac. 15 μl of sample was injected onto the HPLC system (Agilent
1100, with an ACE3 C-18AQ column (1 × 150 mm). RP-HPLC conditions were as follows:
buffer A (ultra-pure Milli-Q water with 0.1% (v/v) formic acid) to a maximum of 50% buffer B
(Acetonitrile with 0.1% (v/v) formic acid) over 128 min at a flow rate of 0.05 ml/min. Muro-
peptides were detected by UV at 205 nm. MS analysis was performed using a modified proto-
col of previously published methods [42]. Muropeptides were analysed by infusion MS by
directing RP-HPLC eluate to the ion source on an LTQmass spectrometer (Thermo). The
spray voltage was set at 3.6 kV and the transfer capillary temperature at 200˚C. Mass spectra
were collected over the range m/z = 300–2000 with MS/MS fragmentation spectra triggered
for ion signals>5 x 103 intensity. Analysis was performed using Xcalibur QualBrowser v2.0
(Thermo).
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Integration of identified muropeptide peaks
For all UV-absorbance peak muropeptide identification by mass spectrometry (MS), the ion of
greatest abundance within a peak was used for peak designation. For monomeric and dimeric
muropeptide species, MS/MS was used to confirm the identity of the most abundant observed
ion. For muropeptide species with greater crosslinking (oligomers), the mass of the most abun-
dant ion found by MS was used to identify the UV-absorbance peak. Relative quantities of
muropeptides were calculated by the normalised percentage area under each peak for which
the chemical structure had been determined.
Zebrafish model of infection
Up to 5 days post fertilization (dpf) zebrafish are not protected under the Animals (Scientific
Procedures) Act 1986. However, all work was carried out according to the stipulations set out
in Project License PPL 40/3574. London wild-type (LWT) strains were used for all zebrafish
experiments in this study. Adult zebrafish were maintained by staff at the University of Shef-
field Bateson Centre Zebrafish Facility. Adult fish were kept in a continuous re-circulating
closed system aquarium with a light/dark cycle of 14/10 hours at 28˚C. LWT zebrafish
embryos/larvae were kept in E3 medium at 28.5˚C.
Zebrafish embryos were dechorionated manually at roughly 28 hpf, before being anaesthe-
tised in 0.02% (w/v) 3-amino benzoic acid ester (tricaine, Sigma) 30 hpf and injected with 1 nl
of bacterial suspension from a calibrated glass needle, as previously described [50]. Injections
into the zebrafish embryo circulation valley were performed using, a pneumatic micropump
(WPI, PV820), a micromanipulator (WPI) and a dissecting light microscope (Leica). After
injection, embryos were placed individually into 96-well plates with 250 μl of E3 per well, and
survival (indicated by presence of a heartbeat) was recorded up to 90 hpi.
To quantify bacterial growth within zebrafish, single larvae were collected with 100 μl E3
medium into 2 ml cap containers (Peqlab). Embryos were individually homogenised using a
PreCellys 24-dual (Peqlab) and the resulting homogenates were serially diluted in sterile PBS
and plated onto TSA as 10 μl spots. The limit of detection for this experiment was 10 CFU/
embryo. Clearance was defined as being below the limit of detection.
Murine sepsis model of infection
Murine work was carried out according to UK law in the Animals (Scientific Procedures) Act
1986, under Project License PPL 40/3699 and Project License P3BFD6DB9 (Staphylococcus
aureus and other pathogens, pathogenesis to therapy).
Mouse injections were performed as previously described [4]. 6–8 weeks old female BALB/
c mice (Charles River Laboratories, UK) were housed in designated animal facilities using
standard husbandry protocols. 100 μl S. aureus was injected intravenously into the tail vein of
7-week-old mice. Inocula CFUs were quantified by serial dilution and plating onto TSA and
incubating overnight at 37˚C, before directly counting CFUs. Weights were recorded daily,
and wellbeing checks were performed twice daily. Mice were monitored and euthanised at 72
hpi (unless otherwise stated in the experimental design) or if mice reached severity limits
described in the protocol defined by the project license.
Individual mouse organs were homogenised in PBS (livers in 3 ml, other organs in 2 ml)
using a PreCellys 24-dual (Peqlab) homogeniser. CFU per organ was determined by plating
10 μl spots of serially diluted homogenate onto TSA for bacterial number determination. Sta-
tistical significance between groups was determined using a Mann- Whitney two-tailed test or
a one way-ANOVA.
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Purified PG required for injections was centrifuged for 2 minutes at 16873 x g and then sus-
pended in sterile endotoxin free PBS before being sonicated at an amplitude of 10 microns for
30 seconds. PG was injected at a dose of 250 μg per mouse at the same time as the bacteria.
Clodronate and empty control PBS liposomes (Liposoma research, The Netherlands,
clodronateliposomes.com) were injected as per manufacturer’s instructions. Clodronate and
control liposomes were injected at a dose of 100 μL of suspension per 10 grams (stock 5 mg
clodronate / mL) intravenously 24 hours before infection. Mice were then infected with 1 x 105
CFU of bacteria.
Relative fitness experiments used a modified version of an existing protocol [46]. 20 mice
were injected with a 1:1 ratio of each strain (totalling 1 x 107 CFU) and culled after 72 hpi.
Organs were individually collected and plated onto TSA containing antibiotics to allow the
counting of the number of each strain within each homogenate. Relative fitness was calculated
using the equation ? = x2(1-x1) /x1(1-x2) (where w = relative fitness, x1 = starting mutant pro-
portion and x2 = ending mutant proportion) [46]. Relative fitness within each organ was then
analysed using a one sample Wilcoxon signed rank test, comparing the results to a theoretical
median of 1, testing if strains deviate from equal fitness.
Clonality experiments were performed as previously described [4]. Strains carrying kana-
mycin or tetracycline resistance were used in this study to allow for selection. These resistances
have previously shown to have no impact upon S. aureus virulence [55]. The resistance cas-
settes were transferred by F11 transduction into NewHG pbp4 following the existing method-
ology [4,55], producing NewHG pbp4 kanR (SJF 5136) and NewHG pbp4 tetR (SJF 5135). Mice
were infected with either wildtype marked strains in a 1:1 ratio or with the NewHG pbp4
marked strains in a 1:1 ratio. 5 mice from each group were culled at 2, 24, 48 and 72 hpi and
each organ was individually collected, homogenised, and the ration of each marked strain
determined. Species evenness was calculated per sample (Shannon’s diversity index (H) was
calculated and then divided by the natural logarithm of species richness) and then linear mean
regression was performed for both the wildtype and pbp4 strain in each organ over time to
compare correlations. The gradient of these lines was compared to determine a change in clon-
ality compared to the wildtype strain.
MDM survival
Monocytes were isolated from peripheral blood mononuclear cells (PBMCs) from healthy
donors, as previously described [18]. Ficoll Plaque (GE Healthcare) density centrifugation was
used to isolate PBMCs from donor blood, which were seeded into 24 well plates (Corning) at 2
x 106 cells/ml in RPMI 1640 medium with the addition of 2 mM/l L-glutamine (Lonza) which
was further supplemented with 10% v/v new-born foetal calf serum (Gibco). Wells contained
approximately 2 x 105 MDM. After incubating for 24 hours at 37˚C with 5% CO2, cells were
washed with fresh RPMI 1640 with 2 mM/l L-glutamine and with 10% v/v low endotoxin heat
inactivated foetal calf serum (Biosera) to remove non-adherent cells. Cells had supernatant
removed twice a week which was replaced with fresh supplemented RPMI 1640 and differenti-
ated MDMs were used at 14 days post isolation. All media and reagents were warmed to 37˚C
prior to contact with MDMs (unless otherwise stated). MDMs were challenged with S. aureus
strains at an MOI of 5 (i.e. 1 x 106 CFU per well of 2 x 105MDMs) in RPMI-1640. MDMs were
challenged with S. aureus for 4 hours at 37˚C, 5% v/v CO2, after which infected media was
removed and MDMs were washed with ice cold PBS. Extracellular bacteria were killed by the
addition of 100 μg/ml gentamicin for 30 min in RPMI-1640 media. MDMs were then incu-
bated in RPMI-1640 supplemented with 4 μg/ml gentamicin and 0.8 μg/ml lysostaphin until
the desired time point. At the desired time points MDMs were washed with PBS and incubated
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for 12 min with 250 μl 2% w/v saponin at 37˚C, 5% CO2. PBS was added to make well volume
1 ml and cells were further lysed by vigorous pipetting, with MDM lysis confirmed by light
microscopy. Viable intracellular CFU was determined by serial dilution, and spotting 10 μl
onto TSA plates, which were incubated at 37˚C overnight. To confirm gentamicin killing of
extracellular bacteria, control MDMs were fixed with 2% v/v paraformaldehyde before bacte-
rial challenge, showing absence of bacteria in lysates after gentamicin treatment. Other control
MDMs were not infected with S. aureus but otherwise treated as above, to confirm that all bac-
teria recovered came from the initial inoculum. All MDM experiments had two biological
repeats for each time point and strain.
Neutrophil survival
Neutrophil work followed a modified protocol previously described [18]. Neutrophils were
purified from anti-coagulated human blood and kept at 37˚C with 5% CO2 (v/v) in RPMI
1640 medium. Neutrophils were kept in 96 well Tissue Culture plates (Corning) containing
90 μl of approximately 2.5 x 106 cells/ml (around 225,000 neutrophils per well). These were
infected with 10 μl of bacterial stock culture to produce a MOI of 5. After 30 minutes, a sample
to calculate phagocytosed bacteria numbers was collected and the remaining cells treated with
gentamicin (to 40 μg/ml). After 60 and 120 min of co-culture, 100 μl of sample was transferred
to a 1.5 ml Eppendorf tube and centrifuged for 3 min at 400 x g to recover neutrophils. Neutro-
phils were washed with 1 ml ice cold sterile PBS, and then lysed with 1 ml room temperature
alkali water (6M NaOH added to dH2O until pH 11) and vigorous pipetting. Intracellular CFU
were determined by serially diluting in sterile PBS and plating 10 μl spots onto TSA, which
were left overnight at 37˚C, and CFU calculated the next day by directly counting.
Flow cytometry
Analysis of S. aureus particle size was analysed by measuring the forward scatter (FSC) of parti-
cles. S. aureus strains were cultured in 24 well plates at 37˚C and 200 rpm until an OD600 of 0.6
(exponential phase) was achieved in 1 ml TSB. Bacteria were diluted 1:100 in PBS filtered
through a 0.2 μm syringe filter. FSC was analysed by flow cytometry using a Millipore Guava
EasyCyte system. Light scatter data were obtained with logarithmic amplifiers for 2500 events,
and each strain was measured in triplicate, from three independent cultures.
Statistical analysis
Statistical analysis was performed using Prism version 8.3.0 (GraphPad). Zebrafish experi-
ments are representative of n = 2 unless otherwise stated, with figures showing combined
results of replicate experiments. Comparison between survival curves was made using the log-
rank (Mantel Cox) test. For bacterial count and weight change comparison in murine experi-
ments the Mann-Whitney U test was used. For comparison of two or more independent sam-
ples simultaneously the Kruskal Wallis test was applied with Dunn’s multiple comparison test.
Shannon’s diversity index was calculated using the equation H ¼  
PR
i¼1 pilnðpiÞ; (where H =
Shannon diversity index and pi = the proportion of species i relative to the total number of spe-
cies present). Species evenness was derived from the Shannon diversity index using the equa-
tion EH = H/lnS (where EH = species evenness, H = Shannon diversity index and S = the total
number of species within the community (species richness)). Species evenness within an organ
over time was analysed using mean linear regression analysis. For relative fitness experiments,




was used and analysed using a one sample Wilcoxon signed rank test
(w = relative fitness, X1 = starting mutant proportion and X2 = ending mutant proportion).
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Supporting information
S1 Fig. Low magnification TEM images of S. aureus and murine kidney homogenate. Thin
section of chemically fixed S. aureus NewHG kanR (SJF 3680) cultured in TSB to (A) exponen-
tial or (B) stationary phase at low magnification (1900 x and 6800 x respectively). (C)NewHG
kanR (SJF 3680) recovered from murine kidneys 72 hpi (6800 x magnification). (D) low mag-
nification (6800 x magnification) TEM images of processed uninfected murine kidney. Scale
bar (blue line) represents 5000 nm for (A), and 1000 nm for (B), (C) and (D).
(PDF)
S2 Fig. The infection dynamics S. aureus pbp4mutants. (A) Approximately 1500 CFU of
bacteria (mutant or wildtype) was injected into the circulation valley of LWT zebrafish
embryos around 30 hpf. Survival curve produced to compare the virulence of parental
NewHG (SJF 3663, WT, black line) to NewHG pbp4::ery (SJF 5103) (3 repeats, n>20). (B-D)
Mice (n = 10) were injected with approximately 1x107 CFU S. aureus NewHG kanR (WT, SJF
3680) or NewHG pbp4::ery (SJF 5103). (B)Weight loss 72 hpi and CFUs recovered from (C)
livers (� p = 0.0294) and (D) kidneys were determined. Groups were compared using a Mann-
Whitney U test (NewHG kanR–black circles, NewHG pbp4::ery blue squares). One mouse was
found dead 72 hpi in the NewHG kanR group and was excluded from the analysis. (E-F)Mice
(n = 20) were injected with a 1:1 ratio (totalling approximately 1 x 107 CFU) of two resistance
marker tagged NewHG variants. 5 mice were culled at each time point and the CFU ratios in
the liver, left kidney, right kidney, spleen, lungs and heart were determined. (E) The propor-
tions of NewHG kanR (SJF 3680, green) and NewHG tetR (SJF 3681, blue) and (F) proportions
of NewHG kanR pbp4::ery (SJF 5136, green) and NewHG tetR pbp4::ery (SJF 5135, blue) recov-
ered at each time point from each organ in each mouse. The number in each pie chart repre-
sents the log number of bacteria recovered (i.e. 106 CFU = 6). H.P.I: hours post infection, M.
N.: Mouse number. Total CFU of recovered NewHG (black circles) and NewHG pbp4::ery
(blue squares) strains from (G) liver, (H) left kidney, (I) right kidney, (J) spleen, (K) lungs and
(L) heart. The population evenness from each mouse at different time points for NewHG kanR
(SJF 3680) and NewHG tetR (SJF 3681) (black circles and lines) and NewHG kanR pbp4::ery
(SJF 5136) and NewHG tetR pbp4::ery (SJF 5135) (blue squares and lines) for (M) livers, (N)
left kidney, (O) right kidney, (P) spleen, (Q) lungs and (R) heart. Lines are mean linear regres-
sion, which were calculated and compared using Prism software. All linear regressions were
found to be non-significant, so the slopes of the lines are not significantly different from one
another. Livers p = 0.6077, Spleen p = 0.2339, Left kidney: p = 0.7691, Right kidney p = 0.6604,
Lungs p = 0.6758 and Heart p = 0.9300. (S) The number of internalised NewHG kanR (SJF
3680, black bars) and NewHG pbp4::ery (SJF 5103, blue bars) and the number remaining in
the extracellular supernatant after 30 min of co-incubation with human neutrophils. Error
bars represent the standard deviation of the mean. (n = 4, each consisting of 3 intra-assay
repeats). Results analysed with a one-way ANOVA with Tukey’s multiple comparison post-
test. (T) Intracellular NewHG kanR (SJF 3680, black circles) and NewHG pbp4::ery (SJF 5103,
blue squares) CFU after co-incubation with neutrophils for 60 or 120 minutes. (n = 4, each
consisting of 3 intra-assay repeats). Error bars represent the mean and standard deviation of
the mean. Results analysed with a two-way ANOVA with Tukey’s correction.
(PDF)
S3 Fig. The role of sagB in the zebrafish embryo model. (A) Survival curves showing the
attenuation of SH1000 sagB::kan (SJF 4608, red line) compared to SH1000 (SJF 682, black
lines) (3 repeats, n>20, ���� p< 0.0001) and (B) the attenuation of NewHG sagB::kan (SJF
4912, red line) compared to parental NewHG (SJF 3663, black lines) (2 repeats, n>20, ��
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p = 0.0043). (C, D) Bacterial CFU were recovered from zebrafish embryos infected with 1500
CFU (C) SH1000 (SJF 682) or (D) SH1000 sagB::kan (SJF 4608) (n = 50–60) or (E)NewHG
(SJF 3663) or (F)NewHG sagB::kan (SJF 4912) (n = 70–85) at times shown. Open black circles
are live embryos and red circles are dead embryos.
(PDF)
S4 Fig. Augmentation of S. aureus strains using staphylococcal peptidoglycan in the
murine sepsis model. Approximately 1x106 CFU of either S. aureus NewHG kanR (WT, SJF
3680), NewHG pbp4::ery (SJF 5103) or NewHG sagB::kan (SJF 4912) with or without 250 μg
WT S. aureus PG injected intravenously into mice (n = 5). (A, E)Weight loss 72 hpi (�
p = 0.0159, �� p = 0.0079) and CFUs recovered from (B, F) livers (� p = 0.0397, �� p = 0.0079)
(C, G) kidneys and (D, H) spleen were determined. Groups were compared using Mann-
Whitney U tests (NewHG kanR–black circles, NewHG pbp4::ery—blue squares, NewHG sagB::
kan–red squares). One mouse (infected with NewHG pbp4::ery and 250 μg PG) was culled at
56 hpi due to reaching severity limits, so was culled. This data is represented as a green dia-
mond but has been excluded from statistical analysis.
(PDF)
S5 Fig. Growth and virulence of NewHG sagB pbp4 in vitro and in the murine sepsis
model. (A) Growth of parental NewHG (SJF 3663, black circles) in TSB compared to: NewHG
sagB::kan (SJF 4912, red squares), NewHG pbp4::ery (SJF 5103, blue diamonds) and NewHG
sagB::kan pbp4::ery (SJF 5147, purple triangles). Bacterial cultures were prepared in triplicate
and error bars represent the standard deviation of the mean. Mice (n = 10) were injected intra-
venously with approximately 1x107 CFU S. aureus NewHG kanR (WT, SJF 3680), NewHG
sagB::kan (SJF 4912), NewHG pbp4::ery (SJF 5103) or NewHG sagB::kan pbp4::ery (SJF 5147).
CFUs recovered from (B) spleens, (C) lungs and (D) hearts were determined. Groups were
compared using a Mann-Whitney U test (NewHG kanR–black circles, NewHG sagB::kan–red
squares, NewHG pbp4::ery blue diamonds, NewHG sagB::kan pbp4::ery–purple triangles).
(PDF)
S6 Fig. Growth and virulence of S. aureus glucosaminidase mutants. Growth (measured by
OD600 and CFU) of parental SH1000 (SJF 682, black circles solid line) or sonicated SH1000
(open black circles and broken line) in TSB compared to: (A, B) SH1000 atl (SJF 1367, yellow
squares) and sonicated SH1000 atl (yellow open squares, broken lines), (D, E) SH1000 sagA
(SJF 4606, blue squares) and sonicated SH1000 sagA (blue open squares, broken lines), (G, H)
SH1000 scaH (SJF 4607, red squares) and sonicated SH1000 scaH (red open squares, broken
lines), (J, K) SH1000 atl sagA (SJF 5261, green squares) and sonicated SH1000 atl sagA (green
open squares, broken lines), (L, M) SH1000 atl scaH (SJF 5262, orange squares) and sonicated
SH1000 atl scaH (orange open squares, broken lines), (N, O) SH1000 sagA scaH (SJF 5217,
purple squares) and sonicated SH1000 sagA scaH (purple open squares, broken lines). Bacte-
rial cultures were prepared in triplicate and error bars represent the standard deviation of the
mean. Sonicated strains were sonicated for 20 seconds at an amplitude of 5 microns. Survival
curves of zebrafish embryos injected with approximately 1500 CFU of S. aureus SH1000 (SJF
682, black lines) or (C) approximately 500 CFU SH1000 atl (1500 CFU after sonication) (SJF
1367, yellow line) (F) approximately 1500 CFU SH1000 sagA (SJF 4606, blue line) or (I)
approximately 1500 CFU SH1000 scaH (SJF 4607, red line). (3 repeats, n>20), all groups are
not significantly different from the parental SH1000 strain.
(PDF)
S7 Fig. The role of Atl, SagA and ScaH in S. aureus growth and virulence. (A,B) Growth of
parental SH1000 (SJF 682, black circles solid line) or sonicated SH1000 (open black circles and
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broken line) in TSB compared to SH1000 atl sagA scaH (SJF 4611, brown squares) and soni-
cated SH1000 atl sagA scaH (brown open squares, broken lines). Organ homogenates from Fig
7G and 7H were sonicated to get a better representation of bacterial load in the (C) livers (p
values on graph) and (D) kidneys (� p = 0.0364, ��� p = 0.0009). Groups were compared using
a Kruskal-Wallis test with multiple comparisons (unsonicated SH1000 kanR–black circles, son-
icated SH1000 kanR–open black circles, unsonicated SH1000 atl sagA scaH—brown squares
and sonicated SH1000 atl sagA scaH–open brown squares). Strains and organ homogenates
were sonicated for 20 seconds at an amplitude of 5 microns. (E-J)Mice (n = 5) were injected
with approximately 1x107 CFU sonicated S. aureus SH1000 atl sagA scaH (SJF 4611) alone, or
with 250 μg SH1000 PG (SJF 682, WT PG) or 250 μg SH1000 atl sagA scaH PG (mutant PG).
(E)Weight loss 72 hpi (�� p = 0.0079, � p = 0.0159) and CFUs recovered from (F) livers (�
p = 0.0159), (G) kidneys (p values on graph), (H) spleen, (I) lungs and (J) heart were deter-
mined. Groups were compared using a Mann-Whitney U test. (SH1000 atl sagA scaH only–
black circles, SH1000 atl sagA scaH with wildtype PG—red squares SH1000 atl sagA scaH with
mutant PG–blue triangles). One mouse in the SH1000 atl sagA scaH and WT PG group
reached severity limits at 48 hpi and was culled and has been excluded from analysis.
(PDF)
S1 Table. S. aureus strains used in this study.
(PDF)
S2 Table. Oligonucleotides used in this study.
(PDF)
S3 Table. Muropeptide database. Identity of S. aureus muropeptides with numbering system
used as a part of this study. The observed retention times, mass and charge states are also
noted.
(PDF)
S4 Table. Raw integration results. Identified and measured peaks of (A-C) exponential phase
S. aureus, (D-F) stationary phase S. aureus and (G-H)murine infection derived S. aureus.
(PDF)
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